After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRDF falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Cardiff Oncology Inc is $154.35M. A total of 1.02 million shares were traded on the day, compared to an average of 1.89M shares.
In the most recent transaction, PACE GARY W bought 275,000 shares of CRDF for 2.45 per share on Jul 30 ’25. After the transaction, the Director now owns 1,330,676 company shares. In a previous transaction on Jul 30 ’25, PACE GARY W bought 15,000 shares at 2.45 per share. CRDF shares that Director owns now total 1,345,676.
Among the insiders who bought shares, Levine James E. acquired of 2,752 shares on Dec 17 ’24 at a per-share price of $5.42. This resulted in the Chief Financial Officer holding 65,316 shares of CRDF after the transaction. In another insider transaction, Levine James E. bought 2,400 shares at $5.00 per share on Dec 18 ’24. Company shares held by the Chief Financial Officer now total 67,716.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRDF has a high of $5.64 and a low of $2.09.
As of this writing, CRDF has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.25 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRDF’s latest balance sheet shows that the firm has $140.82M in Cash & Short Term Investments as of fiscal 2021. There were $3.12M in debt and $6.56M in liabilities at the time. Its Book Value Per Share was $0.88, while its Total Shareholder’s Equity was $140.42M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRDF is Buy with a score of 4.50.
